Exelixis Initiates Phase 3 Pivotal Trial Of Cabozantinib In Combination With Nivolumab And Ipilimumab Versus Nivolumab And Ipilimumab In Previously Untreated Advanced Renal Cell Carcinoma
Benzinga_Newsdesk